MyChesCo on MSN
Ocugen Strikes $187.5 Million Licensing Deal With Kwangdong for Gene Therapy in Korea
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed an exclusive licensing agreement with South Korea’s Kwangdong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback